×
About 288 results

ALLMedicine™ Pediatric HIV Infection Center

Research & Reviews  97 results

Cutaneous Manifestations of HIV
https://emedicine.medscape.com/article/1133746-overview

Mar 20th, 2023 - Overview Cutaneous manifestations of human immunodeficiency virus (HIV) disease may result from HIV infection itself or from opportunistic disorders secondary to the decline in immunocompetence from the disease. [1] Cutaneous disorders may be the ...

Cutaneous Manifestations of HIV
http://emedicine.medscape.com/article/1133746-overview

Mar 20th, 2023 - Overview Cutaneous manifestations of human immunodeficiency virus (HIV) disease may result from HIV infection itself or from opportunistic disorders secondary to the decline in immunocompetence from the disease. [1] Cutaneous disorders may be the ...

Cutaneous Manifestations of HIV
https://emedicine.medscape.com/article/1133746-print

Mar 20th, 2023 - Cutaneous manifestations of human immunodeficiency virus (HIV) disease may result from HIV infection itself or from opportunistic disorders secondary to the decline in immunocompetence from the disease.[1] Cutaneous disorders may be the initial si...

Clinical Outcomes of People Who Acquired HIV in Early Life
https://clinicaltrials.gov/ct2/show/NCT01656564

Mar 9th, 2023 - Background: Antiretroviral therapy (ART) has altered the natural history of HIV disease in children. Long-term survivors of pediatric HIV infection offer a tremendous opportunity to understand the effects of HIV and ART health outcomes. A thorough...

Similar cortical morphometry trajectories from 5 to 9 years in children with perinatal ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951512
BMC Neuroscience; Nwosu EC, Holmes MJ et. al.

Feb 25th, 2023 - Life-long early ART (started before age 2 years), often with periods of treatment interruption, is now the standard of care in pediatric HIV infection. Although cross-sectional studies have investigated HIV-related differences in cortical morpholo...

see more →

Clinicaltrials.gov  13 results

Clinical Outcomes of People Who Acquired HIV in Early Life
https://clinicaltrials.gov/ct2/show/NCT01656564

Mar 9th, 2023 - Background: Antiretroviral therapy (ART) has altered the natural history of HIV disease in children. Long-term survivors of pediatric HIV infection offer a tremendous opportunity to understand the effects of HIV and ART health outcomes. A thorough...

Systems Analysis and Improvement Approach for Prevention of MTC HIV Transmission
https://clinicaltrials.gov/ct2/show/NCT03425136

May 17th, 2022 - Despite significant increases in global health investment and the availability of low-cost, efficacious interventions designed to prevent mother to child HIV transmission (PMTCT) in low and middle income countries with high HIV burden, the transla...

Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Resource-Limited Countries
https://clinicaltrials.gov/ct2/show/NCT01061151

Feb 11th, 2022 - The incidence of mother-to-child transmission (MTCT) of HIV has decreased in recent years in the United States, Europe, and other resource-advantaged countries. Several factors have contributed to this decrease, including the administration of HAA...

Potential of Prebiotic Galacto-oligosaccharides in Improving Efficacy and Safety of Oral Iron Supplementation in HIV-infected Children
https://clinicaltrials.gov/ct2/show/NCT04931641

Jan 21st, 2022 - Iron deficiency anemia (IDA) in childhood can impair growth and cognition, as well as reduce school performance. Furthermore, anemia frequently complicates pediatric HIV infection and predicts disease progression and mortality. However, there is n...

Comparison of Two Dosage Regimens of Oral Dapsone for Prophylaxis of Pneumocystis Carinii Pneumonia in Pediatric HIV Infection
https://clinicaltrials.gov/ct2/show/NCT00000739

Nov 4th, 2021 - Prophylaxis for Pneumocystis carinii pneumonia ( PCP ) is recommended for all HIV-infected children considered to be at high risk. Approximately 15 percent of children are intolerant to trimethoprim / sulfamethoxazole, the first choice drug for PC...

see more →

News  5 results

Fast Five Quiz: How Much Do You Know About HIV?
https://reference.medscape.com/viewarticle/842465_6

Sep 11th, 2020 - The HHS guidelines for laboratory testing in patients with HIV receiving ART recommend a basic chemistry profile every 6 months. A random or fasting lipid profile and glucose profile are recommended every 12 months. A CD4 count is recommended ever...

Pediatric HIV Infection: Drug Development for Treatment
http://www.fda.gov/regulatory-information/search-fda-guidance-documents/pediatric-hiv-infection-drug-development-treatment

Docket Number: FDA-2018-D-1638 Issued by: Guidance Issuing Office Center for Drug Evaluation and Research Center for Biologics Evaluation and Research The purpose of this guidance is to provide general recommendations on the development of antiret...

IVIg Reimbursement Cuts Threaten Patient Access
https://www.mdedge.com/dermatology/article/7387/health-policy/ivig-reimbursement-cuts-threaten-patient-access
Alicia Ault

Physicians as well as patient and industry representatives say that a congressionally imposed reduction in Medicare reimbursement for intravenous immunoglobulin—when combined with several other factors—is having a devastating impact on access to t.

see more →